Condition
Peritoneal Carcinosis
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Not Yet Recruiting2
Unknown1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07478432Not ApplicableNot Yet RecruitingPrimary
Impact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery
NCT07271914Not ApplicableNot Yet Recruiting
PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors
NCT04221464Not ApplicableRecruiting
Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)
NCT02866903Phase 1UnknownPrimary
Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis
Showing all 4 trials